Cochlear Europe Limited is a privately held limited company established in 1999 and currently active. Based at 6 Dashwood Lang Road, Addlestone, KT15 2HJ, the company specializes in the design, development, manufacturing, and marketing of advanced hearing devices. Cochlear’s core business revolves around providing innovative cochlear implants and related technologies to individuals with hearing loss. The company’s primary focus is on restoring hearing and enhancing communication for patients with various types of hearing impairment. Cochlear’s products are designed to address the underlying causes of hearing loss, offering a range of implant options and supporting services. Cochlear operates internationally, with a significant presence in Europe and North America. The company’s international operations are facilitated through a global business mobility program, attracting and retaining skilled professionals. Cochlear’s size estimate is significant, reflecting a substantial investment in research, development, and clinical trials. Cochlear’s key industry focus includes medical device manufacturing, healthcare technology, and clinical services. The company’s SIC codes encompass a broad range of activities related to healthcare, including medical devices, diagnostic imaging, and clinical services.

Cochlear Europe Limited is a privately held limited company established in 1999 and currently active. Based at 6 Dashwood Lang Road, Addlestone, KT15 2HJ, the company specializes in the design, development, manufacturing, and marketing of advanced hearing devices. Cochlear’s core business revolves around providing innovative cochlear implants and related technologies to individuals with hearing loss. The company’s primary focus is on restoring hearing and enhancing communication for patients with various types of hearing impairment. Cochlear’s products are designed to address the underlying causes of hearing loss, offering a range of implant options and supporting services. Cochlear operates internationally, with a significant presence in Europe and North America. The company’s international operations are facilitated through a global business mobility program, attracting and retaining skilled professionals. Cochlear’s size estimate is significant, reflecting a substantial investment in research, development, and clinical trials. Cochlear’s key industry focus includes medical device manufacturing, healthcare technology, and clinical services. The company’s SIC codes encompass a broad range of activities related to healthcare, including medical devices, diagnostic imaging, and clinical services.